BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20976738)

  • 41. Neuropsychological effects of bilateral deep brain stimulation of the subthalamic nucleus in Parkinson's disease.
    Bordini BJ; Garg A; Gallagher CL; Bell B; Garell PC
    Stereotact Funct Neurosurg; 2007; 85(2-3):113-20. PubMed ID: 17228177
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Subthalamic nucleus stimulation does not cause deterioration of preexisting hallucinations in Parkinson's disease patients.
    Yoshida F; Miyagi Y; Kishimoto J; Morioka T; Murakami N; Hashiguchi K; Samura K; Sakae N; Yamasaki R; Kawaguchi M; Sasaki T
    Stereotact Funct Neurosurg; 2009; 87(1):45-9. PubMed ID: 19174620
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-term effects of bilateral subthalamic nucleus stimulation in advanced Parkinson disease: a four year follow-up study.
    Visser-Vandewalle V; van der Linden C; Temel Y; Celik H; Ackermans L; Spincemaille G; Caemaert J
    Parkinsonism Relat Disord; 2005 May; 11(3):157-65. PubMed ID: 15823480
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Deep brain stimulation of the subthalamic nucleus improves cognitive flexibility but impairs response inhibition in Parkinson disease.
    Witt K; Pulkowski U; Herzog J; Lorenz D; Hamel W; Deuschl G; Krack P
    Arch Neurol; 2004 May; 61(5):697-700. PubMed ID: 15148146
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of nigral stimulation on locomotion and postural stability in patients with Parkinson's disease.
    Chastan N; Westby GW; Yelnik J; Bardinet E; Do MC; Agid Y; Welter ML
    Brain; 2009 Jan; 132(Pt 1):172-84. PubMed ID: 19001482
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of levodopa and subthalamic nucleus stimulation on cognitive and affective functioning in Parkinson's disease.
    Funkiewiez A; Ardouin C; Cools R; Krack P; Fraix V; Batir A; Chabardès S; Benabid AL; Robbins TW; Pollak P
    Mov Disord; 2006 Oct; 21(10):1656-62. PubMed ID: 16830317
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cognition following bilateral deep brain stimulation surgery of the subthalamic nucleus for Parkinson's disease.
    Halpern CH; Rick JH; Danish SF; Grossman M; Baltuch GH
    Int J Geriatr Psychiatry; 2009 May; 24(5):443-51. PubMed ID: 19016252
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Does subthalamic nucleus deep brain stimulation really improve quality of life in Parkinson's disease?
    Gronchi-Perrin A; Viollier S; Ghika J; Combremont P; Villemure JG; Bogousslavsky J; Burkhard PR; Vingerhoets F
    Mov Disord; 2006 Sep; 21(9):1465-8. PubMed ID: 16763974
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Coping and quality of life of patients with Parkinson disease who have undergone deep brain stimulation of the subthalamic nucleus.
    Montel SR; Bungener C
    Surg Neurol; 2009 Aug; 72(2):105-10; discussion 110-1. PubMed ID: 18786708
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease.
    Limousin P; Krack P; Pollak P; Benazzouz A; Ardouin C; Hoffmann D; Benabid AL
    N Engl J Med; 1998 Oct; 339(16):1105-11. PubMed ID: 9770557
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Postoperative gait deterioration after bilateral subthalamic nucleus stimulation in Parkinson's disease.
    van Nuenen BF; Esselink RA; Munneke M; Speelman JD; van Laar T; Bloem BR
    Mov Disord; 2008 Dec; 23(16):2404-6. PubMed ID: 18951532
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: long-term follow-up.
    Tavella A; Bergamasco B; Bosticco E; Lanotte M; Perozzo P; Rizzone M; Torre E; Lopiano L
    Neurol Sci; 2002 Sep; 23 Suppl 2():S111-2. PubMed ID: 12548368
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Subthalamic nucleus stimulation applied in the earlier vs. advanced stage of Parkinson's disease - retrospective evaluation of postoperative independence in pursuing daily activities.
    Yamada K; Hamasaki T; Kuratsu J
    Parkinsonism Relat Disord; 2009 Dec; 15(10):746-51. PubMed ID: 19481492
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outcome of bilateral subthalamic nucleus stimulation in the treatment of Parkinson's disease: correlation with intra-operative multi-unit recordings but not with the type of anaesthesia.
    Lefaucheur JP; Gurruchaga JM; Pollin B; von Raison F; Mohsen N; Shin M; Ménard-Lefaucheur I; Oshino S; Kishima H; Fénelon G; Rémy P; Cesaro P; Gabriel I; Brugières P; Keravel Y; Nguyen JP
    Eur Neurol; 2008; 60(4):186-99. PubMed ID: 18667827
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuropsychological performance following staged bilateral pallidal or subthalamic nucleus deep brain stimulation for Parkinson's disease.
    Rothlind JC; Cockshott RW; Starr PA; Marks WJ
    J Int Neuropsychol Soc; 2007 Jan; 13(1):68-79. PubMed ID: 17166305
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuro-psychiatric therapy during chronic subthalamic stimulation in Parkinson's disease.
    Zibetti M; Pesare M; Cinquepalmi A; Rosso M; Castelli L; Rizzi L; Bergamasco B; Lanotte M; Lopiano L
    Parkinsonism Relat Disord; 2009 Feb; 15(2):128-33. PubMed ID: 18515169
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical and neuropsychological follow up at 12 months in patients with complicated Parkinson's disease treated with subcutaneous apomorphine infusion or deep brain stimulation of the subthalamic nucleus.
    De Gaspari D; Siri C; Landi A; Cilia R; Bonetti A; Natuzzi F; Morgante L; Mariani CB; Sganzerla E; Pezzoli G; Antonini A
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):450-3. PubMed ID: 16543520
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term efficacy and mortality in Parkinson's disease patients treated with subthalamic stimulation.
    Toft M; Lilleeng B; Ramm-Pettersen J; Skogseid IM; Gundersen V; Gerdts R; Pedersen L; Skjelland M; Røste GK; Dietrichs E
    Mov Disord; 2011 Aug; 26(10):1931-4. PubMed ID: 21656853
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuropsychological effects of deep brain stimulation in subjects with early stage Parkinson's disease in a randomized clinical trial.
    Tramontana MG; Molinari AL; Konrad PE; Davis TL; Wylie SA; Neimat JS; May AT; Phibbs FT; Hedera P; Gill CE; Salomon RM; Wang L; Song Y; Charles D
    J Parkinsons Dis; 2015; 5(1):151-63. PubMed ID: 25613351
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preserved cognition after deep brain stimulation (DBS) in the subthalamic area for Parkinson's disease: a case report.
    Cyron D; Funk M; Deletter MA; Scheufler K
    Acta Neurochir (Wien); 2010 Dec; 152(12):2097-100. PubMed ID: 20676703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.